CLBT trades 26.6% below Wall Street's consensus target of $14.13.
Last 12 months price action with 12-month analyst target path
The base valuation assumes CLBT achieves its forward estimates and maintains a stable P/E multiple of 40.4x. This scenario reflects the blended consensus of 9 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of November 19, 2026, Cellebrite DI Ltd. (CLBT) has a Wall Street consensus price target of $14.13, based on estimates from 9 covering analysts. With the stock currently trading at $11.16, this represents a potential upside of +26.6%. The company has a market capitalization of $2.78B.
Analyst price targets range from a low of $12.50 to a high of $15.00, representing a 18% spread in expectations. The median target of $14.50 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 9 analysts rating the stock as a Buy or Strong Buy,0 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, CLBT trades at a trailing P/E of 43.5x and forward P/E of 40.4x. Analysts expect EPS to grow +7.6% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $10.35, with bear and bull scenarios of $6.52 and $13.64 respectively. Model confidence stands at 62/100, reflecting moderate uncertainty in projections.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
AXONAxon Enterprise, Inc. | $24.2B | $300.69 | $595.30 | +98.0% | Buy | 39.1x | 22 |
VRNSVaronis Systems, Inc. | $5.7B | $49.23 | $50.75 | +3.1% | Hold | 278.5x | 35 |
OSPNOneSpan Inc. | $848M | $22.87 | $16.00 | -30.0% | Buy | 16.9x | 16 |
NTCTNetScout Systems, Inc. | $2.4B | $33.36 | $43.00 | +28.9% | Hold | 13.8x | 21 |
IIIVi3 Verticals, Inc. | $502M | $21.02 | $26.00 | +23.7% | Buy | 19.6x | 15 |
SPSCSPS Commerce, Inc. | $2.9B | $79.15 | $81.00 | +2.3% | Hold | 15.5x | 23 |
CACICACI International Inc | $13.5B | $609.32 | $757.57 | +24.3% | Buy | 21.6x | 30 |
SAICScience Applications International Corporation | $6.2B | $147.04 | $118.75 | -19.2% | Hold | 14.6x | 18 |
LDOSLeidos Holdings, Inc. | $15.8B | $125.71 | $151.89 | +20.8% | Buy | 10.6x | 28 |
BAHBooz Allen Hamilton Holding Corporation | $10.1B | $84.05 | $92.00 | +9.5% | Buy | 13.8x | 23 |
Quick answers to the most common questions about buying CLBT stock.
The consensus Wall Street price target for CLBT is $14.13, representing 26.6% upside from the current price of $11.16. With 9 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
CLBT has a consensus rating of "Buy" based on 9 Wall Street analysts. The rating breakdown is predominantly bullish, with 9 Buy/Strong Buy ratings. The consensus 12-month price target of $14.13 implies 26.6% upside from current levels.
At a forward P/E of 40.4494x, CLBT trades at a premium valuation. The consensus price target of $14.13 (26.6% upside) suggests analysts still see growth justifying the multiple.
The most bullish Wall Street analyst has a price target of $15 for CLBT, while the most conservative target is $12.5. The consensus of $14.13 represents the median expectation. Our quantitative valuation model projects a bull case target of $14 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
CLBT is moderately covered, with 9 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 9 have Buy ratings, 0 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month CLBT stock forecast based on 9 Wall Street analysts shows a consensus price target of $14.13, with estimates ranging from $12.5 (bear case) to $15 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $10, with bear/bull scenarios of $7/$14.
Our quantitative valuation model calculates CLBT's fair value at $10 (base case), with a bear case of $7 and bull case of $14. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 62/100.
CLBT trades at a forward P/E ratio of 40.4x based on next-twelve-months earnings estimates compared to a trailing P/E of 43.5x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Wall Street analysts are very optimistic on CLBT, with a "Buy" consensus rating and $14.13 price target (26.6% upside). 9 of 9 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
CLBT analyst price targets range from $12.5 to $15, a 18% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $14.13 consensus represents the middle ground. Our model's $7-$14 range provides an independent fundamental perspective.
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.